Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
COVID-19 is a pandemic caused by human coronavirus (HCoV) SARS-CoV-2, which originated in Wuhan, China, at the end of 2019 and spread globally during 2020. Due to the difficulty of clinical decision-making during this period, our study group reviewed current literature focusing on the neurological and psychiatric aspects of COVID-19. Despite the knowledge on this newly discovered virus which is constantly evolving, different pieces of evidence reported an association between COVID-19 and neurological symptoms like headache, dizziness, taste and smell disorders and complications involving the nervous system eventually triggered by the pathologic processes elicited by SARS-CoV-2. It seems that younger patients are less prone to develop severe forms of COVID-19. However, neurological signs have been reported in paediatric patients as well, and in some cases, the infection presented neurological sequelae. Furthermore, children with particular neurological diseases or treated with specific drugs (e.g. immune-suppressant therapies) must be carefully monitored during this pandemic. Neurologists should be aware of the main drug–drug interactions and the neurological side effects of COVID-19 treatments. Notably, adverse mental health impact has been reported in patients with SARS-CoV-2, which could be related either to the social strain or to the eventual neurotropic effects of the virus, which in other infections have been proven to promote the onset of psychiatric symptoms. Further, psychiatric population may be more vulnerable to the infection and at higher risk for adverse outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166 · cited 5×
“Hence, COVID-19 has to be suspected in the differential diagnosis of patients with neurological symptoms, especially in highly epidemic environments [11, 22, 25].”
BackgroundInfluentialFirst case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Holmes, E. A., O'Connor, R. C., Perry, V. H., Tracey, I., Wessely, S., Arseneault, L., Ballard, C., Christensen, H., Cohen Silver, R., Everall, I., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30168-1 · Cited by 5,715
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.013 · Cited by 5,028 · cited 1×
“5 and 6% in retrospective European and Chinese studies [22, 35].”
BackgroundLechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05965-1 · Cited by 2,668 · cited 2×
“Results showed higher rates of OTDs in Europe compared with Asia and highlighted that olfactory disorders (both hyposmia and anosmia) are likely to appear even before other much-known symptoms of the COVID-19 [26].”
BackgroundThe immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596 · cited 1×
“Nonetheless, numerous pieces of evidence have recognized the role of the inflammatory response as a contributor to the pathophysiology of cerebrovascular diseases [37].”
BackgroundLi, Y., Bai, W., & Hashikawa, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25728 · Cited by 2,266 · cited 9×
“Hence, COVID-19 has to be suspected in the differential diagnosis of patients with neurological symptoms, especially in highly epidemic environments [11, 22, 25].”
BackgroundInfluentialBaig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207 · cited 3×
“However, infected glial cells and neurons may also play a significant role in CNS tissue damage, having in vitro properties to secrete inflammatory cytokines and so potentially perpetuating inflammation and causing demyelination, oedema, and longterm neurological sequelae [15, 17, 18, 24].”
BackgroundAlhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105
Galea, S., Merchant, R. M., & Lurie, N. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.1562 · Cited by 2,089
Nervous system involvement after infection with COVID-19 and other coronaviruses
Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., & Yang, C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.031 · Cited by 2,046 · cited 3×
“HCoVs share high similarities and common neurotropic features, and there is no evidence that SARS-CoV-2 may not be an exception [11, 18, 19].”
BackgroundA first case of meningitis/encephalitis associated with SARS-Coronavirus-2
Moriguchi, T., Harii, N., Goto, J., Harada, D., Sugawara, H., Takamino, J., Ueno, M., Sakata, H., Kondo, K., Myose, N., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.062 · Cited by 2,024 · cited 1×
“Nonetheless, similar findings have been reported as well in other patients [28, 29] whose cerebral spinal fluid tested positive for SARS-CoV-2 RNA, suggesting COVID19-related encephalitis.”
ResultLiu, N., Zhang, F., Wei, C., Jia, Y., Shang, Z., Sun, L., Wu, L., Sun, Z., Zhou, Y., Wang, Y., et al. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112921 · Cited by 1,548
Suicide risk and prevention during the COVID-19 pandemic
Gunnell, D., Appleby, L., Arensman, E., Hawton, K., John, A., Kapur, N., Khan, M., O'Connor, R. C., Pirkis, J., Appleby, L., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30171-1 · Cited by 1,513
COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features
Poyiadji, N., Shahin, G., Noujaim, D., Stone, M., Patel, S., & Griffith, B. (2020) · Radiology · doi:10.1148/radiol.2020201187 · Cited by 1,505
Xu, Y., Li, X., Zhu, B., Liang, H., Fang, C., Gong, Y., Guo, Q., Sun, X., Zhao, D., Shen, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0817-4 · Cited by 1,415 · cited 1×
“Focusing on the neurological features, headache has been reported in up to 28% of the cases [71], being the principal neurological symptom, followed by confusion, in this age group [75].”
BackgroundGiacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., Rusconi, S., Gervasoni, C., Ridolfo, A. L., Rizzardini, G., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa330 · Cited by 1,326
Netland, J., Meyerholz, D. K., Moore, S., Cassell, M., & Perlman, S. (2008) · Journal of Virology · doi:10.1128/jvi.00737-08 · Cited by 1,293 · cited 6×
“ACE2 is expressed in the brainstem and the CNS replication of SARS-CoV-2 might directly involve the cardiorespiratory centre [15, 38].”
BackgroundInfluentialTang, W., Hu, T., Hu, B., Jin, C., Wang, G., Xie, C., Chen, S., & Xu, J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.009 · Cited by 787
Neurologic alterations due to respiratory virus infections
Bohmwald, K., Gálvez, N. M. S., Ríos, M., & Kalergis, A. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00386 · Cited by 636 · cited 2×
“It seems that COVID-19 can cause a cytokine storm syndrome which, together with the elevation of D-dimer levels, platelet reduction, and hypoxia, may cause susceptibility to cerebrovascular events [15, 23, 24].”
BackgroundAvula, A., Nalleballe, K., Narula, N., Sapozhnikov, S., Dandu, V., Toom, S., Glaser, A., & Elsayegh, D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.077 · Cited by 558 · cited 2×
“Like other viruses and bacteria, it seems that SARS-CoV-2 as well could trigger acute cerebrovascular diseases (CVD), such as ischemic or haemorrhagic stroke and cerebral venous sinus thrombosis, which have been reported in several patients [22, 33, 34].”
Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43
Dubé, M., Le Coupanec, A., Wong, A. H. M., Rini, J. M., Desforges, M., & Talbot, P. J. (2018) · Journal of Virology · doi:10.1128/jvi.00404-18 · Cited by 452
To, K., & Lo, A. W. (2004) · The Journal of Pathology · doi:10.1002/path.1597 · Cited by 226
Okusaga, O., Yolken, R. H., Langenberg, P., Lapidus, M., Arling, T. A., Dickerson, F. B., Scrandis, D. A., Severance, E., Cabassa, J. A., Balis, T., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.029 · Cited by 163
Cited by
Buselli, R., Corsi, M., Baldanzi, S., Chiumiento, M., Del Lupo, E., Dell'Oste, V., Bertelloni, C. A., Massimetti, G., Dell’Osso, L., Cristaudo, A., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176180 · Cited by 429
Self-citationCOVID‑19 and post‑traumatic stress disorder: The perfect ‘storm’ for mental health (Review)
Giannopoulou, I., Galinaki, S., Kollintza, E., Adamaki, M., Kympouropoulos, S., Alevyzakis, E., Tsamakis, K., Tsangaris, I., Spandidos, D., Siafakas, N., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10596 · Cited by 81
“Indeed, apart from the promi‑ nent respiratory symptoms, SARS‑CoV‑2 has been shown to induce neurological and neuropsychiatric manifestations that vary both in intensity and duration; neurological symptoms include headaches, dizziness, hyposmia or anosmia, ageusia, ataxia, seizures, encephalitis, encephalopathy, senso…”
InfluentialBuselli, R., Corsi, M., Veltri, A., Baldanzi, S., Chiumiento, M., Marino, R., Caldi, F., Perretta, S., Foddis, R., Cristaudo, A., et al. (2022) · International Journal of Occupational Safety and Health · doi:10.3126/ijosh.v12i2.40500 · Cited by 5
Self-citationBuselli, R., Corsi, M., Veltri, A., Baldanzi, S., Chiumiento, M., Del Lupo, E., Marino, R., Necciari, G., Caldi, F., Perretta, S., et al. (2022) · Workplace Health & Safety · doi:10.1177/21650799211045715 · Cited by 2
“The best choice seems to be drugs that do not act, or act very little, on cytochrome P450, and this is the reason why we opted for valproate as adjunct therapy (Orsini et al., 2020).”
BackgroundSelf-citation
Metadata
- Authors
- Orsini, A., Corsi, M., Santangelo, A., Riva, A., Peroni, D., Foiadelli, T., Savasta, S., & Striano, P.
- Venue
- Neurological Sciences
- Published
- 2020-08-06
- Volume
- 41
- Issue
- 9
- Pages
- 2353-2366
- ISSN
- 1590-1874 (ISSN-L)
- 1590-3478
- OpenAlex
- W3048355617
- Cited by
- 84
- References
- 24
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.